| Lizenz: Creative Commons Namensnennung-NichtKommerziell 3.0 de PDF - Veröffentlichte Version (1MB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-751557
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.75155
Zusammenfassung
Oncogenic mutated Ras is a key player in cancer, but despite intense and expensive approaches its catalytic center seems undruggable. The Ras dimer interface is a possible alternative drug target. Dimerization at the membrane affects cell growth signal transduction. In vivo studies indicate that preventing dimerization of oncogenic mutated Ras inhibits uncontrolled cell growth. Conventional ...

Nur für Besitzer und Autoren: Kontrollseite des Eintrags

Downloadstatistik